mercredi 7 octobre 2015

Onco Actu du 7 octobre 2015


3.1 Tabac

FDA launches national public education campaign to prevent and reduce tobacco use among multicultural youth [FDA]

4.5 Dép., diag. & prono. - Colorectal

Exact Sciences Shares Plunge, Questions Arise for Insurers, Doctors [Xconomy]

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Colorectal Cancer [US Preventive Services Task Force]

Exact Sciences Tumbles on Colon Cancer Screening Snub [TheStreet]

4.8 Dép., diag. & prono. - Droit

Patient wins high court challenge against company's cancer gene patent [The Guardian]

5.12 Immunothérapies

The Landscape of Cancer: Immunotherapy Shining Through [The OBR Blog]

Investigating an Alternative Approach to Cancer Immunotherapy: Eliminating Immune System-suppressing Treg Cells [CANCER RESEARCH Catalyst]

Transforming Cancer Treatment with Immunotherapy (TechVision) [ReportLinker]

5.2 Pharma

Advaxis offers a tardy defense after FDA puts cancer vaccine on hold [FierceBiotech]

Advaxis Reports Clinical Hold of Investigational Agent Axalimogene Filolisbac [Advaxis]

FDA puts clinical hold on Advaxis cancer drug [Reuters]

5.2.1 Pharma - Partenariats

MD Anderson, Theraclone Sciences form OncoResponse [MD Anderson Cancer Center]

5.3 Traitements - FDA, EMA,...

Why the FDA should take more chances on riskier drugs [Pharmalot]

5.4 Traitements - Economie

Fast-tracked skin cancer drug pembrolizumab gets approval [BBC News]

6. Lutte contre les cancers

Freezing Ovaries Before Cancer Treatment May Preserve Fertility [NPR]

6.1 Observation

First HIV, then cancer [Hutch News]

6.11 Patients

Henning Mankell: ‘Eventually the day comes when we all have to go’ [The Guardian]

6.6 Publications

There’s “no evidence” research was conducted at all in retracted cancer paper [Retraction Watch]

6.7 DMP, Big Data & applis

Roche CEO: Big Data needs Big Pharma, and vice versa [FiercePharma]